1. Home
  2. PCAP vs HUMA Comparison

PCAP vs HUMA Comparison

Compare PCAP & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCAP
  • HUMA
  • Stock Information
  • Founded
  • PCAP 2025
  • HUMA 2004
  • Country
  • PCAP United States
  • HUMA United States
  • Employees
  • PCAP N/A
  • HUMA N/A
  • Industry
  • PCAP
  • HUMA Biotechnology: Pharmaceutical Preparations
  • Sector
  • PCAP
  • HUMA Health Care
  • Exchange
  • PCAP Nasdaq
  • HUMA Nasdaq
  • Market Cap
  • PCAP 324.1M
  • HUMA 324.0M
  • IPO Year
  • PCAP 2025
  • HUMA N/A
  • Fundamental
  • Price
  • PCAP $10.38
  • HUMA $1.70
  • Analyst Decision
  • PCAP
  • HUMA Strong Buy
  • Analyst Count
  • PCAP 0
  • HUMA 7
  • Target Price
  • PCAP N/A
  • HUMA $10.00
  • AVG Volume (30 Days)
  • PCAP 78.8K
  • HUMA 7.6M
  • Earning Date
  • PCAP 01-01-0001
  • HUMA 11-07-2025
  • Dividend Yield
  • PCAP N/A
  • HUMA N/A
  • EPS Growth
  • PCAP N/A
  • HUMA N/A
  • EPS
  • PCAP N/A
  • HUMA N/A
  • Revenue
  • PCAP N/A
  • HUMA $818,000.00
  • Revenue This Year
  • PCAP N/A
  • HUMA N/A
  • Revenue Next Year
  • PCAP N/A
  • HUMA $1,686.52
  • P/E Ratio
  • PCAP N/A
  • HUMA N/A
  • Revenue Growth
  • PCAP N/A
  • HUMA N/A
  • 52 Week Low
  • PCAP $9.64
  • HUMA $1.15
  • 52 Week High
  • PCAP $11.42
  • HUMA $6.77
  • Technical
  • Relative Strength Index (RSI)
  • PCAP N/A
  • HUMA 48.64
  • Support Level
  • PCAP N/A
  • HUMA $1.61
  • Resistance Level
  • PCAP N/A
  • HUMA $1.90
  • Average True Range (ATR)
  • PCAP 0.00
  • HUMA 0.11
  • MACD
  • PCAP 0.00
  • HUMA -0.01
  • Stochastic Oscillator
  • PCAP 0.00
  • HUMA 43.48

About PCAP ProCap Acquisition Corp Class A Ordinary Shares

ProCap Acquisition Corp is a blank check company.

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: